Results 1 - 20 of 8,835 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
- Peer-reviewed Journals (8,448)
Refined by:
subject:
Antibodies, Monoclonal, Humanized - Therapeutic Use
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 1 |
Material Type: Article
|
|
Lecanemab in Early Alzheimer’s DiseaseThe New England journal of medicine, 2023-01, Vol.388 (1), p.9-21 [Peer Reviewed Journal]Copyright © 2022 Massachusetts Medical Society. All rights reserved. ;Copyright © 2022 Massachusetts Medical Society. ;COPYRIGHT 2023 Massachusetts Medical Society ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2212948 ;PMID: 36449413Full text available |
| 2 |
Material Type: Article
|
|
The antibody aducanumab reduces Aβ plaques in Alzheimer's diseaseNature (London), 2016-09, Vol.537 (7618), p.50-56 [Peer Reviewed Journal]ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature19323 ;PMID: 27582220Full text available |
| 3 |
Material Type: Article
|
|
Phase I Trial: Cirmtuzumab Inhibits ROR1 Signaling and Stemness Signatures in Patients with Chronic Lymphocytic LeukemiaCell stem cell, 2018-06, Vol.22 (6), p.951-959.e3 [Peer Reviewed Journal]2018 ;Copyright © 2018. Published by Elsevier Inc. ;ISSN: 1934-5909 ;EISSN: 1875-9777 ;DOI: 10.1016/j.stem.2018.05.018 ;PMID: 29859176Full text available |
| 4 |
Material Type: Article
|
|
A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitorsBlood, 2019-12, Vol.134 (24), p.2127-2138 [Peer Reviewed Journal]2019 American Society of Hematology ;2019 by The American Society of Hematology. ;2019 by The American Society of Hematology 2019 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood.2019001869 ;PMID: 31697801Full text available |
| 5 |
Material Type: Article
|
|
T-cell invigoration to tumour burden ratio associated with anti-PD-1 responseNature (London), 2017-05, Vol.545 (7652), p.60-65 [Peer Reviewed Journal]COPYRIGHT 2017 Nature Publishing Group ;COPYRIGHT 2017 Nature Publishing Group ;Copyright Nature Publishing Group May 4, 2017 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature22079 ;PMID: 28397821Full text available |
| 6 |
Material Type: Article
|
|
Vedolizumab as Induction and Maintenance Therapy for Ulcerative ColitisThe New England journal of medicine, 2013-08, Vol.369 (8), p.699-710 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1215734 ;PMID: 23964932 ;CODEN: NEJMAGFull text available |
| 7 |
Material Type: Article
|
|
Vedolizumab as Induction and Maintenance Therapy for Crohn's DiseaseThe New England journal of medicine, 2013-08, Vol.369 (8), p.711-721 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1215739 ;PMID: 23964933 ;CODEN: NEJMAGFull text available |
| 8 |
Material Type: Article
|
|
Emicizumab, a bispecific antibody recognizing coagulation factors IX and X: how does it actually compare to factor VIII?Blood, 2017-12, Vol.130 (23), p.2463-2468 [Peer Reviewed Journal]2017 American Society of Hematology ;2017 by The American Society of Hematology. ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-08-801662 ;PMID: 29042366Full text available |
| 9 |
Material Type: Article
|
|
Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody SotrovimabNew England Journal of Medicine, 2021-11, Vol.385 (21), p.1941-1950 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2107934 ;PMID: 34706189Digital Resources/Online E-Resources |
| 10 |
Material Type: Article
|
|
Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic SyndromeThe New England journal of medicine, 2013-06, Vol.368 (23), p.2169-2181 [Peer Reviewed Journal]Copyright © 2013 Massachusetts Medical Society. All rights reserved. ;2014 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1208981 ;PMID: 23738544 ;CODEN: NEJMAGFull text available |
| 11 |
Material Type: Article
|
|
Focal Irradiation and Systemic TGFβ Blockade in Metastatic Breast CancerClinical cancer research, 2018-06, Vol.24 (11), p.2493-2504 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Jun 1, 2018 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-17-3322 ;PMID: 29476019Full text available |
| 12 |
Material Type: Article
|
|
Phase I Study of Single-Agent Utomilumab (PF-05082566), a 4-1BB/CD137 Agonist, in Patients with Advanced CancerClinical cancer research, 2018-04, Vol.24 (8), p.1816-1823 [Peer Reviewed Journal]2018 American Association for Cancer Research. ;Copyright American Association for Cancer Research Inc Apr 15, 2018 ;ISSN: 1078-0432 ;EISSN: 1557-3265 ;DOI: 10.1158/1078-0432.CCR-17-1922 ;PMID: 29549159Full text available |
| 13 |
Material Type: Article
|
|
A Monoclonal Antibody for Malaria PreventionThe New England journal of medicine, 2021-08, Vol.385 (9), p.803-814 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2034031 ;PMID: 34379916Full text available |
| 14 |
Material Type: Article
|
|
Casirivimab/Imdevimab: First ApprovalDrugs (New York, N.Y.), 2021-11, Vol.81 (17), p.2047-2055 [Peer Reviewed Journal]The Author(s), under exclusive licence to Springer Nature Switzerland AG 2021 ;2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG. ;Copyright Springer Nature B.V. Nov 2021 ;ISSN: 0012-6667 ;EISSN: 1179-1950 ;DOI: 10.1007/s40265-021-01620-z ;PMID: 34716907Full text available |
| 15 |
Material Type: Article
|
|
Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β 2 -agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trialThe Lancet (British edition), 2016-10, Vol.388 (10056), p.2115 [Peer Reviewed Journal]Copyright © 2016 Elsevier Ltd. All rights reserved. ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(16)31324-1 ;PMID: 27609408Full text available |
| 16 |
Material Type: Article
|
|
Defucosylated Anti-CCR4 Monoclonal Antibody (KW-0761) for Relapsed Adult T-Cell Leukemia-Lymphoma: A Multicenter Phase II StudyJournal of clinical oncology, 2012-03, Vol.30 (8), p.837-842 [Peer Reviewed Journal]2015 INIST-CNRS ;ISSN: 0732-183X ;EISSN: 1527-7755 ;DOI: 10.1200/JCO.2011.37.3472 ;PMID: 22312108Full text available |
| 17 |
Material Type: Article
|
|
Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled period of the phase III trial SPIRIT-P1Annals of the rheumatic diseases, 2017-01, Vol.76 (1), p.79-87 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/. ;Copyright: 2016 Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing ;Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ 2016 ;ISSN: 0003-4967 ;EISSN: 1468-2060 ;DOI: 10.1136/annrheumdis-2016-209709 ;PMID: 27553214 ;CODEN: ARDIAOFull text available |
| 18 |
Material Type: Article
|
|
A phase 1 trial of vadastuximab talirine as monotherapy in patients with CD33-positive acute myeloid leukemiaBlood, 2018-01, Vol.131 (4), p.387-396 [Peer Reviewed Journal]2018 American Society of Hematology ;2018 by The American Society of Hematology. ;2018 by The American Society of Hematology 2018 ;ISSN: 0006-4971 ;EISSN: 1528-0020 ;DOI: 10.1182/blood-2017-06-789800 ;PMID: 29196412Full text available |
| 19 |
Material Type: Article
|
|
Strategies and challenges for the next generation of antibody-drug conjugatesNature reviews. Drug discovery, 2017-05, Vol.16 (5), p.315-337 [Peer Reviewed Journal]Copyright Nature Publishing Group May 2017 ;ISSN: 1474-1776 ;EISSN: 1474-1784 ;DOI: 10.1038/nrd.2016.268 ;PMID: 28303026Full text available |
| 20 |
Material Type: Article
|
|
Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Science, 2021-02, Vol.371 (6531) [Peer Reviewed Journal]2021. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abf9302Digital Resources/Online E-Resources |
Results 1 - 20 of 8,835 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
- Peer-reviewed Journals (8,448)
Refine My Results
Creation Date
- Before 2009 (3)
- 2009 To 2011 (361)
- 2012 To 2014 (3,408)
- 2015 To 2018 (2,010)
- After 2018 (3,054)
-
More options
New Records
- New From Last Month (43)
- New From Last 3 Month (143)
-
More options
Resource Type
- Articles (8,820)
- magazinearticle (9)
- Conference Proceedings (3)
- Book Chapters (2)
- Web Resources (1)
-
More options
Subject
- Humans (8,748)
- Science & Technology (7,949)
- Life Sciences & Biomedicine (7,690)
- Female (4,868)
- Male (4,110)
- Middle Aged (3,330)
- Adult (2,732)
- Treatment Outcome (2,610)
- Aged (2,497)
- Oncology (2,123)
- Antibodies, Monoclonal, Humanized - Adverse Effects (1,629)
- Monoclonal Antibodies (1,536)
- Patients (1,415)
- Medicine (1,355)
- Medicine & Public Health (1,258)
- Antineoplastic Agents - Therapeutic Use (1,153)
- Immunotherapy (1,072)
- Bevacizumab (1,057)
- Antibodies, Monoclonal - Therapeutic Use (1,034)
-
More options
Databases
- MEDLINE (8,834)
- ProQuest Central (5,010)
- Geneva Foundation Free Medical Journals at publisher websites (3,258)
- PubMed Central (2,959)
- DOAJ Directory of Open Access Journals (2,293)
- ROAD: Directory of Open Access Scholarly Resources (1,589)
- HighWire Press (Free Journals) (1,402)
- Springer Nature OA Free Journals (810)
- ProQuest One Psychology (537)
- Wiley Online Library Open Access (501)
- IngentaConnect (349)
- BMJ Journals (Open Access) (273)
- Nature Free (265)
- Taylor & Francis Open Access (241)
- Journals@Ovid Open Access Journal Collection Rolling (223)
- Coronavirus Research Database (187)
- PLoS (159)
- Freely Accessible Japanese Titles (151)
- Free E- Journals (110)
- Wolters Kluwer Open Access (110)
-
More options
Language
Journal Title
- Annals Of Oncology (112)
- Annals Of The Rheumatic Diseases (170)
- Blood (100)
- Clinical Cancer Research (107)
- Immunotherapy (104)
- Journal Of Clinical Oncology (125)
- Medicine (105)
- Plos One (153)
- Rheumatology (158)
- The New England Journal Of Medicine (213)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||